Cargando…
COVID-19 and Light Chain Amyloidosis, Adding Insult to Injury
Light chain (AL) amyloidosis is a potentially fatal disease of monoclonal plasma cells that leads to accumulation of light chain amyloid fibrils, organ damage, and the manifestations of clinical disease. Meanwhile, coronavirus disease 2019 (COVID-19) is a disease caused by infection with the severe...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783834/ https://www.ncbi.nlm.nih.gov/pubmed/35081378 http://dx.doi.org/10.1016/j.amjmed.2022.01.005 |